Automated Liquid Handling Technologies Market Segmentation by Product Type - Multipurpose Workstation | Pipetting Workstation | Specialized Liquid Handler | Workstation Module
Industry: Healthcare
Published Date: November-2022
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 296
Report ID: PMRREP33208
The global Automated Liquid Handling Technologies market size was valued at USD 1.70 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 11% from 2022 to 2032.
The introduction of novel automated liquid handling workstations for non-contact dispensing is anticipated to drive the market. Over the years, contact dispensing gained wide acceptance due to its reliability, simplicity, and low cost. However, the liquid handling needs have changed with decreasing sample volume.
|
Report Attributes |
Details |
|
Automated Liquid Handling Technologies Market Size (2022) |
US$ 1.89 billion |
|
Projected Market Value (2032F) |
US$ 5.36 billion |
|
Global Market Growth Rate (2022-2032) |
11% CAGR |
|
Key Companies |
|
The global COVID-19 pandemic brought a greater necessity for the collection and preparing virus samples safely, accurately, and quickly. This is putting pressure on the laboratories to meet the demand for high-throughput and large-scale testing.
In such life-threatening circumstances, preserving samples and reducing the risk of contamination is important, hence, dependency on automated liquid handling systems that require nominal supervision while safeguarding verifiable and repeatable results has become a standard. Solutions like the PIPETMAX offer effective handling for assays of large quantities, making it the ultimate laboratory assistant. PIPETMAX is suitable for numerous applications, such as cell-based assays and qPCR. It also requires a small footprint and comes with validated, pre-developed protocols.
Manufacturers have developed workstations based on different technologies to dispense the droplet from the dispensing tool by overcoming surface adhesion. These technologies include ultrasound, piezoelectric, and solenoid. For instance, LABCYTE INC. uses Echo acoustic liquid handling technology in its products to offer non-contact dispensing.
In addition, effective miniaturization of the assay platforms reduces workflow expenditure, thereby decreasing the usage of expensive reagents. Miniaturized platforms are developed for highly précised liquid handling for different processes such as plate washing, bulk dispensing, and liquid transfer. Some of the leading providers of small benchtop workstations are Hamilton Company, PerkinElmer, Beckman Coulter, and LABCYTE INC.
Considering the aforementioned factors, the global Automated Liquid Handling Technologies market size is projected to be valued at USD 5.36 billion in 2032.
Rising technological advancements anticipated to drive the global market
The adoption of artificial intelligence in automated liquid handling to control various stages of the procedure and exploit the capability of internet connectivity to interact with the handlers remotely has further offered lucrative opportunities during the study period. By depending on machine learning, the software will offer high levels of error controlling and adapt the activity of instruments to new situations such as reacting to a defect in a disposable tip or compensating for the blockage of the nozzle, which might happen during the handling of the samples. In addition, new product launches augment the growth of the market.
For instance, in December 2021, DISPENDIX launched the I.DOT DW, the latest system in the I.DOT range of products. The I.DOT is the first instrument available around the globe to integrate a built-in drop detection system and can distinguish when operators run out of source liquid, while at the same time validating dispensing volume.
Due to the advantages offered by automation, most genomics laboratories nowadays are considering liquid handling automation to make the sequencing workflow more cost-effective and efficient, thereby driving the market. Furthermore, a study of the breakdown of cost for genome sequencing revealed that 15% of the overall cost relates to the laboratory workers in a conventional clinical laboratory. Laboratories having a Hamilton Microlab STARlet for automated sample preparation revealed that the salaries of laboratory staff dropped after the implementation of automated techniques. Additionally, beyond cost, robots can also carry out repetitive and tedious tasks accurately and tirelessly, presenting an enormous advantage over manual liquid handling.
An increase in the outsourcing of pharma and biotech workflows has led CROs and CMOs to enhance their workflow efficiency in compliance with regulatory requirements. Therefore, many CROs and CMOs are integrating automated liquid handling in their facilities. For instance, in June 2022, Societal CDMO, Inc. announced a new customer project using its automated lyophilization and fill/finish line unit at the company’s San Diego facility.
Possible Lack of Accuracy Restraining the Market Growth
Automated liquid handlers can take the human variable out of pipetting, offering more repeatability. However, they are still subject to multiple errors. If automated liquid handlers are not dispensing the desired number of critical reagents, it is likely that unseen errors will increasingly appear as a process continues. Considering this, the market is expected to restrain the market growth.
Well Established Distribution Network to Drive Market For Automated Liquid Handling Technologies
North America dominates the market with a revenue share of over 35.0% owing to the well-established distribution network of the major market players and rapid adoption of advanced automation solutions. Demand for small volume genomic and proteomics analysis for life science research further fuels growth in this region. Competitors in this region have collaborated with large academic universities and research centers in Europe to increase their revenue.
However, the rise in local biotech companies, an increase in funding support, CFDA reform in China, and the price reform in Japan (affecting both off-patent and on-patent products) are anticipated to foster the progress of the biopharmaceutical industry. The rapid progress of the biopharma and biotechnology companies and CROs and CDMOs in countries such as Japan and China is projected to fuel growth in the APAC region during the forecast period.
Why are Manufacturers of Automated Liquid Handling Technologies Investing in the U.S.?
Automation in medical laboratories to boost the US market
The United States is known for its automation in medical laboratories and has been witnessing an increasing trend, including research and diagnostic laboratories, such as clinical chemistry, hematology, and molecular biology. According to the Foundation-Keybridge Equipment & Software Investment Momentum Monitor, US investment in clinical equipment increased at a 0.7% annualized rate in Q2 2021 and was up 19% year over year in August 2021.
The United States faces a shortfall in laboratory scientists and lab personnel, which is expected to spearhead lab automation across the country. The Department of Labor and Statistics predicts a future shortage of more than 150,000 clinical laboratory scientists exacerbated by a wave of retirements that would see much-qualified personnel leave the workforce over the coming years. Around 5,000 American lab professionals enter the labor pool each year, less than half of the approximately 12,000 workers a year necessary to meet the rising demand for their services.?
Furthermore, strict regulations imposed by the U.S. government and the FDA, along with the growing demand in the diagnostic market is fueling the regional market.
How Will the Asia Pacific Countries Automated Liquid Handling Technologies Market Evolve?
Increasing Spending in Diagnostic Centers to Boost the Regional Market Growth
In May 2022, according to data from the Ministry of Commerce and Industry, the hospitals and diagnostic centers sector in India experienced a 39% increase in Foreign Direct Investment (FDI) fund infusion during the fiscal year 2021-22, with fund infusion totaling approximately USD 697.5 million, this is expected to provide positive boost to the market growth.
Due to the developments in the field of R&D, many public institutions are expected to enhance their laboratory capabilities across the countries, boosting the demand for lab automation equipment.
Which Type of Automated Liquid Handling Technologies Accounts for the Highest Demand?
Automated liquid handling workstations to account for a high market share
The automated liquid handling workstations segment holds the largest share of over 55.0%. Automated liquid handling workstations can be further classified based on their assembly and type. Based on their assembly, these devices are segmented into standalone and integrated workstations and based on type, they are segmented into multipurpose workstations, pipetting workstations, specialized liquid handlers, and workstation modules.
The growing competition among pharmaceutical companies and their pursuit of new drugs to treat diseases effectively drive the adoption of automated workstations. The small footprint and ability to increase with other devices with nanoliter capabilities contribute to higher market penetration of standalone pipettors.
The pipetting workstation segment is expected to dominate the market during the forecast period. Strategic activities by key market players are fueling the growth of the segment. For instance, in November 2021, Tianlong launched an automated pipetting workstation that is designed as a significant tool for PCR setup, which automates error-prone, tedious manual tasks and provides reliable sample mixing and exceptional pipetting performance to regulate the results.
By Application, Which Segment is Driving Market Growth?
Drug discovery and ADME-Tox research Segment type is expected to grow at a significant rate
The drug discovery and ADME-Tox research segment dominates the market with a share of over 35.0%. Over a million compounds are screened to identify a new drug candidate in a single drug discovery experiment. Microarray technology presents the typical requirements of liquid handling such as high throughput, low volume, and high accuracy and precision. Various applications in drug discovery and ADME-Tox include stepwise serial dilution over a wide concentration range, selection and transfer of compounds for the retest, and confirmatory and further analysis. Plate-to-plate dilutions, plate replications, and plate reformatting are the major applications for which automated liquid handling workstations are used in drug discovery and ADME-Tox research. The ability to integrate different types of liquid handlers and stackers or incubators to improve throughput is a major advantage of using automated liquid handling platforms in drug discovery.
The adoption of automated liquid handling technologies for genomic and cancer research is anticipated to witness significant growth. Automated liquid handling is an essential part of cancer and genomic research as it requires dispensing protein or DNA solutions onto substrates or microwells. The subsequent steps involving synthesis and analysis usually require dispensing of additional solutions. The use of manual liquid handling techniques for these becomes impractical and tedious.
By End-User, Which Segment is Accounting for the Highest Share?
Drug discovery and ADME-Tox research Segment type is expected to grow at a significant rate
Pharmaceutical and biotechnology companies dominate the market with a revenue share of over 35.0%. Automated liquid handlers were pioneered for drug discovery laboratories. The regular need to disburse the liquid samples on various substrates and transfer them to containers of various sizes is contributing to their rapid growth in drug development and manufacturing. Owing to this increase in the use of automation for drug screening and drug development, pharma and biotech companies are estimated to maintain their lead in the market in the years to come.
Furthermore, academic and research institutes involved in life science experiments, especially those involving gene sequencing, antibody testing, drug, screening, and protein crystallization, usually need to handle very small sample volumes. Thus, demand for automated methods such as sensor-integrated robotic systems is anticipated to boost revenue growth in the academic and research institutes segment.
Top companies in the Automated Liquid Handling Technologies market are focusing on advancing their research and fast-tracking the development of new Automated Liquid Handling Technologies to launch new products and gain a competitive advantage over other market players.
Major players are channeling efforts toward expanding their production capacities to strengthen their market share. Market expansion is anticipated to be aided by the growing number of partnerships and collaborations among key players that are looking to increase their presence in the market.
By Product
By Application
By End-User
By Region
To know more about delivery timeline for this report Contact Sales
The global Automated Liquid Handling Technologies market accounts for a revenue of US$ 1.89 billion in 2022.
The global market for Automated Liquid Handling Technologies is expected to reach US$ 5.36 billion by 2032.
Demand for Automated Liquid Handling Technologies from 2022 to 2032 is projected to expand at a stellar CAGR of 11%.
By 2032, the automated liquid handling workstations segment holds the largest share of over 55.0%.
Key suppliers of Automated Liquid Handling Technologies are Agilent Technologies; Aurora Biomed, Inc.; AUTOGEN, INC.; Danaher; BioTek Instruments, Inc.; Analytik Jena AG; Corning Incorporated; Eppendorf AG; Formulatrix, Inc.; Gilson, Inc.; Hamilton Company; Hudson Robotics; LABCYTE INC.; Lonza; PerkinElmer, Inc.; QIAGEN; Thermo Fisher Scientific, Inc.; Tecan Trading AG; and METTLER TOLEDO.
